Cargando…

Exacerbated inflammatory cellular immune response characteristics of HAM/TSP is observed in a large proportion of HTLV-I asymptomatic carriers

BACKGROUND: A small fraction of Human T cell Leukemia Virus type-1 (HTLV-I) infected subjects develop a severe form of myelopathy. It has been established that patients with HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) show an exaggerated immune response when compared with the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Santos, Silvane Braga, Porto, Aurélia Fonseca, Muniz, André Luiz, de Jesus, Amélia Ribeiro, Magalhães, Elza, Melo, Ailton, Dutra, Walderez O, Gollob, Kenneth J, Carvalho, Edgar M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC385233/ https://www.ncbi.nlm.nih.gov/pubmed/15070424 http://dx.doi.org/10.1186/1471-2334-4-7

Ejemplares similares

HAM/TSP in relatives of HAM/TSP cases and in relatives of asymptomatic HTLV-1 carriers
por: Alvarez, Carolina, et al.
Publicado: (2014)

Proteomic profiles among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Temoche, Morayma, et al.
Publicado: (2014)

Vestibulospinal tract dysfunction in HTLV-1-asymptomatic infection and in HAM/TSP
por: Labanca, Ludimila, et al.
Publicado: (2014)

Integration site analysis in Japanese HTLV-1 infected asymptomatic carriers and HAM/TSP patients
por: Niederer, Heather, et al.
Publicado: (2014)

HTLV-1 proviral integration sites differ between asymptomatic carriers and patients with HAM/TSP
por: Niederer, Heather A, et al.
Publicado: (2014)

Evaluation of interleukin-32 and cyclooxygenase-2 expression in HAM/TSP patients and HTLV-1 asymptomatic carriers
por: Hatatian, Niayesh, et al.
Publicado: (2021)

HTLV-1 proviral load of HAM/TSP patients according to new diagnostic criteria of HAM/TSP
por: Grassi, Maria F R, et al.
Publicado: (2011)

Early diagnosis of HTLV-1-associated myelopathy (HAM/TSP) in HTLV-1 carrier clinic
por: Matsuzaki, Toshio, et al.
Publicado: (2014)

HTLV-1 HBZ Protein Resides Exclusively in the Cytoplasm of Infected Cells in Asymptomatic Carriers and HAM/TSP Patients
por: Forlani, Greta, et al.
Publicado: (2019)

A NKG2D Thr72Ala polymorphism is not associated with HAM/TSP and proviral load values in Peruvian HTLV-1 infected patients with HAM/TSP and asymptomatic carriers
por: Bernia, Cynthia, et al.
Publicado: (2015)

Clinical manifestations in HTLV-1 infected individuals without HAM/TSP: Results of an 8 years cohort
por: Tanajura, Davi, et al.
Publicado: (2014)

HTLV-1 proviral load as an indicative marker of HAM/TSP: a systematic review of studies of patients with HAM/TSP
por: Bassi, Shiva Shaan, et al.
Publicado: (2014)

Opposite effect of Valproate on Tax and HBZ expression in T-lymphocytes from HTLV-1 asymptomatic carriers and HAM/TSP patients
por: Belrose, Gildas, et al.
Publicado: (2011)

Role of HTLV-1 Tax and HBZ in the Pathogenesis of HAM/TSP
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2017)

Association Between HTLV-1 Genotypes and Risk of HAM/TSP
por: Saito, Mineki
Publicado: (2019)

Differential expression in genes involved in the NF-κβ pathway among asymptomatic HTLV-1 carriers and HAM/TSP patients in Peru
por: Talledo, Michael, et al.
Publicado: (2014)

Neurological manifestations in HTLV-1 patients with overactive bladder syndrome. A precursor of HAM/TSP?
por: Costa, Davi, et al.
Publicado: (2011)

Inflammation with HTLV-1-specific CTLs occurs in the spinal cord of HTLV-1 carriers and the brain of the patients with HAM/TSP
por: Matsuura, Eiji, et al.
Publicado: (2014)

Human T-lymphotropic Virus Type I (HTLV-I) Proviral Load and Clinical Features in Iranian HAM/TSP Patients: Comparison of HTLV-I Proviral Load in HAM/TSP Patients
por: Vakili, Rosita, et al.
Publicado: (2013)

HAM/TSP introduction: systematic review of HAM/TSP clinical trials
por: Anderson, Rebecca, et al.
Publicado: (2014)

An interferon signature is associated with HAM/TSP but not viral containment in HTLV-1 infection
por: Tattermusch, Sonja, et al.
Publicado: (2011)

HAM/TSP Pathogenesis: The Transmigration Activity of HTLV-1-Infected T Cells into Tissues
por: Nakamura, Tatsufumi
Publicado: (2023)

Correlation of HTLV-1 proviral load and lymphocyte proliferation from asymptomatic HTLV-1-positive patients and HAM/TSP patients associated or not to skin disorders
por: Okajima, Renata, et al.
Publicado: (2014)

The Impact of Immune Response on HTLV-I in HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Rafatpanah, Houshang, et al.
Publicado: (2013)

High HTLV-I proviral load in patients with HAM/TSP and ATLL but not with other disorders
por: Altamirano, Natalia, et al.
Publicado: (2011)

Molecular and clinical analyses of HTLV-1 subgroups associated with the risk of developing HAM/TSP.
por: Saito, Mineki, et al.
Publicado: (2015)

Immunovirological markers in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
por: Enose-Akahata, Yoshimi, et al.
Publicado: (2019)

Molecular characterization of HTLV-1 gp46 glycoprotein from health carriers and HAM/TSP infected individuals
por: Mota-Miranda, Aline C A, et al.
Publicado: (2013)

Refining the risk of HTLV-1-associated myelopathy in people living with HTLV-1: identification of a HAM-like phenotype in a proportion of asymptomatic carriers
por: Harding, Daniel, et al.
Publicado: (2022)

Comparison of HTLV-I Proviral Load in Adult T Cell Leukemia/Lymphoma (ATL), HTLV-I-Associated Myelopathy (HAM-TSP) and Healthy Carriers
por: Akbarin, Mohammad Mehdi, et al.
Publicado: (2013)

Managing HAM/TSP with Fampridine
por: Menna-Barreto, M Marcio
Publicado: (2014)

HTLV-1 Integration into Transcriptionally Active Genomic Regions Is Associated with Proviral Expression and with HAM/TSP
por: Meekings, Kiran N., et al.
Publicado: (2008)

Nutritional status and behavioral factors of individuals with HTLV-1 and tropical spastic paraparesis (HAM / TSP)
por: Carvalho, Catia L, et al.
Publicado: (2015)

Characteristics of HAM/TSP after kidney transplantation from HTLV-1 positive living donors
por: Kimura, Miyuna, et al.
Publicado: (2015)

Cyclosporine for the Treatment of HTLV-1-Induced HAM/TSP: An Experience from a Case Report
por: Sánchez-Montalvá, Adrián, et al.
Publicado: (2015)

Hypovitaminosis D Is Associated with Higher Levels of Inflammatory Cytokines and with HAM/TSP in HTLV-Infected Patients
por: Netto, Elaine Coutinho, et al.
Publicado: (2021)

Comparison of Static Balance Control in Infected Htlv-1 Subjects with Different Tsp/Ham Diagnosis
por: Costa, Kelly Helorany Alves, et al.
Publicado: (2022)

Interferon Beta-1a Improves Urinary Symptoms, Reduces Proviral Load, and Modifies the Immune Response in a Patient with HAM/TSP
por: Costa, Davi Tanajura, et al.
Publicado: (2012)

Anti-HTLV antibody profiling reveals an antibody signature for HTLV-I-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP)
por: Burbelo, Peter D, et al.
Publicado: (2008)

CD64 as a biomarker and therapeutic target in HAM/TSP and HTLV-1-associated Infective Dermatitis
por: Khouri, Ricardo, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sd5r0qjet7sgu8n0vvc5ocnla4